Pay in 4 interest-free payments of $6.17 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
A supplementary application for the 9 mg dose has been accepted for review by China NMPA, based on the GLORY-2 results showing 20% weight loss
Australian Therapeutic Goods Administration (TGA) : Banned for injection use
This separation means the compounds do not compete for the same binding sites and do not trigger redundant signaling cascades
FDA Approval for Weight Loss In late 2023, tirzepatide received FDA approval under the brand name Zepbound for chronic weight management
US$ 25.40
US$ 25.71
US$ 21.93
US$ 25.91
US$ 24.97
